Hepatitis Outlook: March 2017

From the Journals
Hepatitis Outlook: March 2017
Publish date: April 19, 2017
By: Richard Pizzi ID Practitioner

Here’s a quick look at some notable news items and journal articles published over the past month, covering the major hepatitis viruses.

In patients with chronic HCV treatment-naïve genotype 1, starting treatment with ledipasvir/sofosbuvir in patients with the absence of fibrosis or with mild fibrosis, compared with those with advanced fibrosis, reduces disease burden and is associated with cost savings, according to a Spanish study in the Journal of Viral Hepatitis.

Continue reading...